These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1732053

  • 21. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
    Moradpour D, Compagnon B, Wilson BE, Nicolau C, Wands JR.
    Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
    [Abstract] [Full Text] [Related]

  • 22. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
    Horak E, Hartmann F, Garmestani K, Wu C, Brechbiel M, Gansow OA, Landolfi NF, Waldmann TA.
    J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
    [Abstract] [Full Text] [Related]

  • 23. Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
    Moseley KR, Battaile A, Knapp RC, Haisma HJ.
    Int J Cancer; 1988 Sep 15; 42(3):368-72. PubMed ID: 3417365
    [Abstract] [Full Text] [Related]

  • 24. Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR.
    van Ravenswaay Claasen HH, Eggermont AM, Nooyen YA, Warnaar SO, Fieuren GJ.
    Gynecol Oncol; 1994 Feb 15; 52(2):199-206. PubMed ID: 8314139
    [Abstract] [Full Text] [Related]

  • 25. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K, Asai T, Shigematsu H, Shimizu K, Kato H, Asano Y, Takashima S, Mekada E, Oku N, Minamino T.
    J Control Release; 2012 Jun 10; 160(2):274-80. PubMed ID: 22020380
    [Abstract] [Full Text] [Related]

  • 26. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 27. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H.
    Int J Pharm; 2007 Sep 05; 342(1-2):194-200. PubMed ID: 17583453
    [Abstract] [Full Text] [Related]

  • 28. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 29. Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
    Garrido MA, Valdayo MJ, Winkler DF, Titus JA, Hecht TT, Perez P, Segal DM, Wunderlich JR.
    Cancer Res; 1990 Jul 15; 50(14):4227-32. PubMed ID: 2142014
    [Abstract] [Full Text] [Related]

  • 30. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T, Okochi E, Ariyoshi K, Watabe H, Amann E, Mori S, Tsuruo T, Ono K.
    Cancer Res; 1993 Nov 15; 53(22):5475-82. PubMed ID: 8106147
    [Abstract] [Full Text] [Related]

  • 31. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 32. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H, Lindegren S, Back T, Jacobsson L, Leser G, Horvath G.
    Anticancer Res; 2000 Apr 15; 20(1A):459-62. PubMed ID: 10769696
    [Abstract] [Full Text] [Related]

  • 33. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
    Koning GA, Gorter A, Scherphof GL, Kamps JA.
    Br J Cancer; 1999 Aug 15; 80(11):1718-25. PubMed ID: 10468287
    [Abstract] [Full Text] [Related]

  • 34. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status.
    Phillips NC, Gagne L, Tsoukas C, Dahman J.
    J Immunol; 1994 Mar 15; 152(6):3168-74. PubMed ID: 7908302
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY, Guo L, Gong YC, Li ZL, Li YP, Liu ZY, Zhou M.
    Eur J Pharm Sci; 2012 Aug 15; 46(5):537-44. PubMed ID: 22538053
    [Abstract] [Full Text] [Related]

  • 37. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S.
    Clin Cancer Res; 2003 Dec 15; 9(17):6551-9. PubMed ID: 14695160
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation.
    Strobel T, Swanson L, Cannistra SA.
    Cancer Res; 1997 Apr 01; 57(7):1228-32. PubMed ID: 9102203
    [Abstract] [Full Text] [Related]

  • 40. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW.
    Cancer Res; 2005 Dec 15; 65(24):11631-8. PubMed ID: 16357174
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.